光动力疗法
免疫原性细胞死亡
癌症研究
活性氧
肿瘤微环境
钙网蛋白
化学
酞菁
免疫疗法
光敏剂
肝细胞癌
程序性细胞死亡
生物物理学
肿瘤缺氧
纳米医学
细胞外
CD8型
树突状细胞
渗透(HVAC)
单线态氧
细胞毒性
材料科学
细胞生长
阳离子聚合
细胞
水溶液
联合疗法
体内
医学
作者
Fang‐Cheng Jiang,Yue Qin,Li Gao,Suning Li,Wei Su,Xuemei Sun,Xin Chen,Ying Wang,Zhen‐Bo Feng,Zefeng Lai
摘要
Background: Photodynamic therapy (PDT) eliminates malignancies through spatially controlled reactive oxygen species (ROS) generation and has achieved clinical success in localized tumors. Nevertheless, its therapeutic potential is severely restricted by the poor aqueous solubility, suboptimal ROS generation efficiency, and oxygen dependency of conventional photosensitizers. To address these limitations, we developed cationic silicon phthalocyanine nanoparticles (c-SPNPs) by self-assembling morpholine-modified silicon phthalocyanine, which significantly improves aqueous solubility. Results: Unlike conventional oxygen-dependent Type II PDT, c-SPNPs work primarily through Type I photochemical mechanism, generating ROS with reduced oxygen consumption. Mechanistically, c-SPNP-mediated PDT induces immunogenic cell death (ICD) in hepatocellular carcinoma (HCC) cells, as evidenced by the release of damage-associated molecular patterns (DAMPs), including surface-exposed calreticulin (CRT), extracellular ATP and HMGB1. These DAMPs promote dendritic cell maturation and enhance CD8 + T-cell infiltration within the tumor microenvironment. In murine HCC models, c-SPNP-mediated PDT effectively suppressed tumor growth while eliciting systemic antitumor immunity. Conclusion: Our study establishes c-SPNPs as a multifunctional nanoplatform that synergizes oxygen-efficient PDT and immunotherapy, offering a promising strategy for hypoxic solid tumor treatment. Keywords: cationic silicon phthalocyanine nanoparticles, hypoxia, immunogenic cell death, photodynamic therapy, tumor microenvironment
科研通智能强力驱动
Strongly Powered by AbleSci AI